Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able to slow eye tumor growth with an existing FDA-approved drug.
Thousands of well-educated foreign-trained physicians in California face daunting barriers to becoming doctors here, and UC San Diego School of Medicine physicians are trying to help – out of altruism and to improve patient care in San Diego County.
Researchers at the University of California, San Diego School of Medicine have identified a mutated gene common to adenosquamous carcinoma (ASC) tumors – the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.
An international team of scientists, including researchers at the UC San Diego School of Medicine and Scripps Institution of Oceanography, report that the likely cause of Kawasaki disease in Japan is a windborne agent originating from northeast China, a region characterized by dense cereal croplands.
Researchers at University of California, San Diego School of Medicine and Moores Cancer Center have used computer simulations of cancer cells – cancer avatars – to identify drugs most likely to kill cancer cells isolated from patients’ brain tumors.
An international team of scientists, including researchers from the University of California, San Diego, report that the likely causative agent of Kawasaki disease (KD) in Japan is a windborne agent originating from a source in northeast China. KD is a mysterious childhood ailment that can permanently damage coronary arteries.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
